SCHEMBL7987138

SCHEMBL7987138

CCn1cnc(C)c1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 4/20 0.44
GAA P10253 1/20 0.44
TSHR P16473 1/20 0.44
NPC1 O15118 2/20 0.38
FDPS P14324 1/20 0.37
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
ABCC4 O15439 1/20 0.35
LMNA P02545 1/20 0.35
PTGS1 P23219 1/20 0.35
RAB9A P51151 1/20 0.34
KDM4E B2RXH2 1/20 0.33
BRD4 O60885 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
POLB P06746 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
PI4KA P42356 1/20 0.33
PI4K2B Q8TCG2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24376040 0.80 ALDH1A1 (0.46) GAAKMT2ALMNARAB9AKDM4E
SCHEMBL28765941 0.78 PKM (0.39) PKMGAATSHRFDPSLMNA
SCHEMBL4802244 0.74 PTGS2 (0.53) PKMGAATSHRNPC1KMT2A
SCHEMBL28220341 0.74 KDM4E (0.36) PKMGAATSHRKMT2AMEN1
SCHEMBL3054669 0.74 APOBEC3A (0.42) PKMGAATSHRNPC1KMT2A
SCHEMBL30671602 0.73 KDM4C (0.38) PKMGAATSHRKMT2AMEN1
SCHEMBL20038434 0.73 PKM (0.51) PKMGAATSHRKMT2AMEN1
SCHEMBL23716719 0.72 APOBEC3A (0.41) PKMGAATSHRNPC1KMT2A
SCHEMBL28565106 0.70 SMN1; SMN2 (0.42) GAANPC1KMT2ARAB9AKDM4E
SCHEMBL11541975 0.69 HCAR3 (0.45) PKMGAATSHRNPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12479834-B2 Phenol compound or salt thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2025-11-25 US disclosed
US-20230049402-A1 NOVEL PHENOL COMPOUND OR SALT THEREOF TAIHO PHARMACEUTICAL CO. LTD. (JP) 2023-02-16 US disclosed
EP-4067343-A1 NOVEL PHENOL COMPOUND OR SALT THEREOF Taiho Pharmaceutical Co., Ltd. (JP) 2022-10-05 EP disclosed
WO-2021106230-A1 NOVEL PHENOL COMPOUND OR SALT THEREOF 大鵬薬品工業株式会社 2021-06-03 WO disclosed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12479834-B2 Phenol compound or salt thereof REN, MLX, MYB PKM 3542/4885GAA 2659/4885TSHR 1888/4885
US-20230049402-A1 NOVEL PHENOL COMPOUND OR SALT THEREOF MYB, MLX, EP300 PKM 3441/4885GAA 3048/4885TSHR 2462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.